Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.

Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.

Item
http://www.wikidata.org/entity/Q37532952
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cComprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH)Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcomeA phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemiaBIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients.Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia.Chronic lymphocytic leukaemia genomics and the precision medicine era.Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia.BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia.
P2860

Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.

Item
http://www.wikidata.org/entity/Q37532952
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Patients with chronic lymphocy ...... .3 have a very poor prognosis.
@en
Patients with chronic lymphocy ...... .3 have a very poor prognosis.
@nl
type
label
Patients with chronic lymphocy ...... .3 have a very poor prognosis.
@en
Patients with chronic lymphocy ...... .3 have a very poor prognosis.
@nl
prefLabel
Patients with chronic lymphocy ...... .3 have a very poor prognosis.
@en
Patients with chronic lymphocy ...... .3 have a very poor prognosis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Patients with chronic lymphocy ...... .3 have a very poor prognosis.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932